SCHEMBL6984133

SCHEMBL6984133

COc1ccc2c(-c3ccncc3)csc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PDGFRB P09619 2/20 0.42
PDGFRA P16234 2/20 0.42
CYP17A1 P05093 1/20 0.42
MAPK14 Q16539 5/20 0.42
CYP11B1 P15538 2/20 0.42
CYP11B2 P19099 2/20 0.42
MAPK13 O15264 2/20 0.42
MAPK12 P53778 2/20 0.42
MAPK11 Q15759 2/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CYP3A4 P08684 1/20 0.41
GCGR P47871 2/20 0.40
GABRA1 P14867 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6981985 0.98 MAPT (0.43) MAPTMEN1KMT2ASMN1; SMN2PDGFRB
SCHEMBL6979513 0.90 CYP3A4 (0.50) CYP17A1MAPK14NPC1CYP3A4GCGR
SCHEMBL5815037 0.89 MAOB (0.44) MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL8341333 0.86 PIN1 (0.51) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL6981655 0.84 KDM4E (0.55) MAPTMEN1KMT2ASMN1; SMN2CYP17A1
Hydrochloric Acid SCHEMBL6982572 0.83 KDM4E (0.54) MAPTMEN1KMT2ASMN1; SMN2CYP17A1
SCHEMBL4744399 0.83 MIF (0.48) MAPTMEN1KMT2AMAPK14GCGR
SCHEMBL22871555 0.83 MAPK13 (0.44) MAPTSMN1; SMN2MAPK14MAPK13MAPK12
SCHEMBL5043116 0.83 LSS (0.54) MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL5045447 0.83 APP (0.49) MAPTMEN1KMT2AMAPK14MAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030130340-A1 Novel benzothiophene derivatives DAIICHI PHARMACEUTICAL CO. LTD. 2003-07-10 US disclosed
EP-1283209-A1 NOVEL BENZOTHIOPHENE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130340-A1 Novel benzothiophene derivatives CYP17A1, CYP21A2, HSD17B1 MAPT 2409/4885MEN1 3356/4885KMT2A 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.